Viewing Study NCT06555133


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2025-12-30 @ 5:29 PM
Study NCT ID: NCT06555133
Status: RECRUITING
Last Update Posted: 2025-04-09
First Post: 2024-05-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
Sponsor: Brown University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module